Advancements in our understanding of genetics have the potential to change the practice of medicine and enable genomics-based healthcare. With streamlined workflows and advanced informatics, Illumina sequencing and array technologies and analysis services are allowing you to explore the genome more than ever before.
Together, we can address healthcare in ways never before imagined.
New discoveries are rapidly advancing our understanding of disease-causing mutations and genetic predispositions. Leveraging this information in a clinical environment can make it more readily accessible, hopefully leading to better patient care. Illumina offers solutions specific for cystic fibrosis screening and diagnosis, kits for developing your own assays using next-generation sequencing, and arrays for detecting cytogenomic abnormalities. Learn more about Illumina molecular diagnostics »
As we gain new insights into our DNA, we are learning how to make sense of the information it contains and what it means for us and our children. Next-generation sequencing technology is leading this revolution, making it easier and more cost effective to access the genome. Benefiting from these advancements, TruGenome Clinical Sequencing Services enable physicians to make genetically informed decisions personalized for each patient. Learn more about TruGenome Clinical Sequencing Services »
Next-generation sequencing offers a new paradigm in HLA typing: unambiguous, phase-resolved typing for eight HLA loci in a single assay. Generated data is more comprehensive and higher in resolution than conventional methods, yielding accurate results across HLA genes and thousands of unique HLA alleles. Learn more about HLA Sequencing »
TruSight sequencing panels pre-populated with expert-defined content for specific diseases or health conditions enable all laboratories to realize the benefits of next-generation sequencing. Clinical research laboratories can use the panels to expand existing menus, streamline workflows, and create an entire portfolio of sequencing options, while increasing productivity, reducing handling errors, and decreasing costs. Learn more about the TruSight sequencing panels »
Clinical informatics tools enable the translation of next-generation sequencing data into clinically meaningful information. The VariantStudio data analysis software application assists with the identification and classification of disease-relevant variants, and communication of findings in concise, actionable reports. The Illumina MyGenome App enables users to explore our current understanding of genomic variation on an iPad. Learn more about Illumina clinical informatics tools »
Illumina sequencing may have uncovered the mutation responsible for a young girl’s rare genetic disorder. Read the article »
Be a part of the movement that engages, educates, and motivates the medical community to improve overall human health.
Get genomed »
Next-generation sequencing technology can help find the underlying genetic component of a disease or health condition.
Read the introduction »
Microarrays detect associations between common single nucleotide polymorphisms (SNPs) in diseases in a fast, cost-effective manner.
Read the eBook »